Phase 2 Study of Indomethacin Capsules to Treat Dental Pain

Iroko Pharmaceuticals

Status and phase: Completed; Phase 2

Conditions: Dental Pain

Treatments: Drug: Indomethacin Test (lower dose); Drug: Placebo; Drug: Indomethacin Test (upper dose); Drug: Celecoxib 400 mg

Study type: Interventional

Funder types: Industry

Identifiers

NCT00964431

IND2-08-03

Details and patient eligibility

About

The purpose of this study is to determine whether Indomethacin Test Formulation Capsules are safe and effective for the treatment of dental pain.

Enrollment: 203 patients

Sex: All

Ages: 18 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient is male or female between 18 and 50 years of age
• For women of child-bearing potential: a woman who is not pregnant and not nursing, and who is practicing an acceptable method of birth control
• Patient requires extraction of 2 or more third molars
• Patient must be willing to stay at the study site for at least 8 hours after dosing of the study drug

Exclusion criteria

• Patient has hypersensitivity, allergy, or clinically significant intolerance to any medications to be used in the study, or related drugs
• Patient has a current disease or history of a disease that will impact the study or the patient's well-being
• Patient has used or intends to use any of the medications that are prohibited by the protocol
• Patient has a history of drug or alcohol abuse or dependence, or patient has a positive urine drug screen or alcohol breathalyzer test
• Patient has taken another investigational drug within 30 days prior to Screening

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

203 participants in 4 patient groups, including a placebo group

Indomethacin Test (lower dose)

Experimental group

Treatment:

Drug: Indomethacin Test (lower dose)

Indomethacin Test (upper dose)

Experimental group

Description:

Single dose

Treatment:

Drug: Indomethacin Test (upper dose)

Celecoxib 400 mg

Active Comparator group

Treatment:

Drug: Celecoxib 400 mg

Placebo

Placebo Comparator group

Treatment:

Drug: Placebo